首页> 外文期刊>Psychoneuroendocrinology: An International Journal >Decreased inhibitory activity of PKC in OCD patients after six months of treatment.
【24h】

Decreased inhibitory activity of PKC in OCD patients after six months of treatment.

机译:治疗六个月后,强迫症患者的PKC抑制活性降低。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We investigated 5-HT reuptake and protein kinase of type C (PKC) activation in platelets of 14 OCD patients at baseline and after six months of treatment with different serotonin (5-HT) reuptake inhibitors (SRIs).The results showed that all SRIs provoked a significant increase in both the maximal velocity (V(max)) and the Michaelis-Menten constant (K(m)) of 5-HT reuptake, as compared with baseline values. The activation of PKC by means of 4-beta-12-tetradecanoylphorbol 13-acetate provoked a significant decrease in V(max) values, but the effect was not as evident as at baseline.These findings could indicate that, in OCD patients, SRIs increase the rate of reuptake and decrease the inhibitory effect of PKC and that the two phenomena may be linked, the first perhaps depending upon the second.
机译:我们调查了14位OCD患者在基线时以及使用不同的5-羟色胺(5-HT)再摄取抑制剂(SRI)治疗六个月后血小板中的5-HT再摄取和C型蛋白激酶(PKC)活化的结果。结果显示,所有SRI与基线值相比,引起了5-HT再摄取的最大速度(V(max))和米氏常数(K(m))的显着增加。通过4-β-12-十四烷酰佛波醇13-乙酸酯激活PKC导致V(max)值显着降低,但效果不如基线时明显。这些发现可能表明,在强迫症患者中,SRIs增加再摄取率并降低PKC的抑制作用,并且可能将这两种现象联系在一起,第一种可能取决于第二种。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号